Breaking News Instant updates and real-time market news.

MENT

Mentor Graphics

$28.81

0.44 (1.55%)

, SNPS

Synopsys

$59.62

-0.13 (-0.22%)

16:32
10/18/16
10/18
16:32
10/18/16
16:32

Appeals Court confirms Mentor Graphics victory, Synopsys patents invalid

Mentor Graphics (MENT) announced that a panel of judges for the Court of Appeals for the Federal Circuit has, in a precedential opinion, unanimously confirmed the invalidity of three synthesis patents owned by Synopsys (SNPS). Synopsys had asserted the patents against Mentor Graphics in the Federal District Court for the Northern District of California, alleging that Mentor Graphics emulators and FPGA synthesis tools infringed the patents. The District Court in 2015 determined that the patents were invalid. Yesterday, the Court of Appeals affirmed the District Court's decision.

MENT

Mentor Graphics

$28.81

0.44 (1.55%)

SNPS

Synopsys

$59.62

-0.13 (-0.22%)

MENT Mentor Graphics
$28.81

0.44 (1.55%)

02/22/16
02/22/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on the today's top five analyst upgrades with this list compiled by The Fly: 1. CSX (CSX) upgraded to Buy from Neutral at BofA/Merrill by analyst Ken Hoexter, who also increased his price target to $28 from $25. He said overall industry volume comps begin to get easier beginning in April and believes CSX's multiple should expand as volume stabilize and coal pressures subside. Hoexter also upgraded Knight Transportation (KNX) and Swift Transport (SWFT) to Buy from Neutral and Werner (WERN) and Genesee & Wyoming (GWR) upgraded to Neutral from Underperform. 2. WellCare (WCG) upgraded to Overweight from Neutral at JPMorgan by analyst Gary Taylor, who raised his price target to $114 from $80. Taylor cited an improved Medicare Advantage outlook following the Centers for Medicare and Medicaid Services' 2017 Advance Notice and said the agency's decision to not explicitly recoup the 2017 HIP Holiday is "quite material" to WellCare. WEllCare was also upgraded to Neutral from Underperform at Bofa/Merrill. 3. Cree (CREE) upgraded to Overweight from Neutral at Piper Jaffray by analyst Mike Ritzenthaler after his firm's channel checks with lighting distributors indicated solid volume growth in the order books for 2016. 4. Mentor Graphics (MENT) upgraded to Buy from Neutral at DA Davidson as it believes that the company's announcement that it will repurchase 8.1M shares from Carl Icahn, along with what the firm sees as stabilizing industry fundamentals, has improved the stock's risk/reward ratio. 5. IMAX (IMAX) upgraded to Outperform from Netural at Wedbush by analyst Michael Pachter. The valuation is favorable while the company is seeing an improving pace of screen installations and an improving premium film slate in 2016, Pachter said. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/19/16
DADA
08/19/16
DOWNGRADE
DADA
Neutral
Mentor Graphics downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Thomas Diffely downgraded Mentor Graphics to Neutral following solid Q2 results based on share valuation.
10/10/16
DADA
10/10/16
UPGRADE
DADA
Buy
Mentor Graphics upgraded to Buy from Neutral at DA Davidson
10/10/16
DADA
10/10/16
UPGRADE
DADA
Buy
Mentor Graphics upgraded on multiple catalysts at DA Davidson
As noted earlier, DA Davidson upgraded Mentor Graphics to Buy from Neutral. Analyst Thomas Diffely says that the company is benefiting from multiple catalysts, including exposure to vertical markets that will enable multi-year growth, solid cash flow, and an activist investor that can help the company unlock value. He thinks that the company can benefit by optimizing its operations, and he finds the stock's valuation attractive. Target to $32 from $24.
SNPS Synopsys
$59.62

-0.13 (-0.22%)

06/06/16
RBCM
06/06/16
INITIATION
Target $64
RBCM
Outperform
Synopsys initiated with an Outperform at RBC Capital
RBC Capital analyst Mitch Steves initiated Synopsys with an Outperform and $64 price target. The analyst said Synopsys has an attractive financial model with licensing revenue, 30% exposure to IP, Systems, and Software, material cash flow yield of 22%, M&A success, and an attractive valuation.
06/24/16
RBCM
06/24/16
NO CHANGE
RBCM
Cisco, Cadence, Synopsys shares should be owned, says RBC Capital
RBC Capital recommends owning Cisco (CSCO), Cadence (CDNS) and Synopsys (SNPS) in the wake of Brexit. Cisco will be seen as a "safe haven," while Cadence and Synopsys won't be affected by Brexit because of their three year licensing deals, the firm stated.
08/18/16
NEED
08/18/16
NO CHANGE
Target $60
NEED
Buy
Synopsys price target raised to $60 from $54 at Needham
Needham analyst Richard Valera raised his price target for Synopsys to $60 from $54 after the company delivered upside top and bottom line results in Q3 and increased its 2016 guidance. The analyst believes Synopsys is gaining share in its hardware business, while also "holding its own" on renewals with its consolidated semi customers. Valera expects the company to continue to perform "solidly" despite the tough macro backdrop. He reiterates a Buy rating on the shares.
10/10/16
DADA
10/10/16
NO CHANGE
DADA
Synopsys price target raised to $100 from $75 at DA Davidson
DA Davidson analyst Thomas Diffely raised his price target on Synopsys citing "solid EDA industry fundamentals" and the "strong operating models" of companies in the sector. Given these factors, Diffely, who identifies Synopsys as his favorite EDA name, thinks that the company deserves a higher multiple. He keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

OHI

Omega Healthcare

$32.53

-0.12 (-0.37%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Hot Stocks
Omega Healthcare provides hurricane update »

Omega Healthcare provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

F

Ford

$11.72

0.09 (0.77%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Periodicals
Ford to slash production at five North American assembly plants, Reuters says »

Ford announced it intends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 26

    Oct

FDX

FedEx

$216.00

0.92 (0.43%)

18:26
09/19/17
09/19
18:26
09/19/17
18:26
Hot Stocks
FedEx says without cyberattack FY18 guidance would not have changed »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

EE

El Paso Electric

$54.85

0.05 (0.09%)

18:25
09/19/17
09/19
18:25
09/19/17
18:25
Hot Stocks
El Paso Electric announces City of El Paso approved settlement terms »

El Paso Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

18:17
09/19/17
09/19
18:17
09/19/17
18:17
Hot Stocks
Bed Bath & Beyond says biggest component in drop of FY17 EPS view is operations »

Company dropped its FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CPRT

Copart

$32.54

-0.32 (-0.97%)

18:11
09/19/17
09/19
18:11
09/19/17
18:11
Earnings
Copart reports Q4 EPS 30c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

STLD

Steel Dynamics

$33.83

0.03 (0.09%)

18:04
09/19/17
09/19
18:04
09/19/17
18:04
Earnings
Steel Dynamics sees Q3 adjusted EPS 63c-67c, consensus 70c »

Steel Dynamics provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBKS

Xenith Bankshares

$29.96

0.42 (1.42%)

17:58
09/19/17
09/19
17:58
09/19/17
17:58
Hot Stocks
Treasury exits stake in Xenith Bankshares »

Xenith Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$62.93

0.23 (0.37%)

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Periodicals
Breaking Periodicals news story on Bristol-Myers »

Times:NHS will supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

BBBY

Bed Bath & Beyond

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

DESP

Despegar.com

17:52
09/19/17
09/19
17:52
09/19/17
17:52
Syndicate
Despegar.com 12.7M share IPO priced at $26.00 »

The IPO priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WAC

Walter Investment

$0.65

0.186 (40.09%)

17:50
09/19/17
09/19
17:50
09/19/17
17:50
Hot Stocks
Walter Investment says Barclays to increase financing available »

On September 13, Walter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49
Initiation
CymaBay initiated  »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

BBBY

Bed Bath & Beyond

17:46
09/19/17
09/19
17:46
09/19/17
17:46
Hot Stocks
Bed Bath & Beyond sees net drop in Bed Bath & Beyond stores in FY17 »

Says rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45
Initiation
Evolent Health initiated  »

Evolent Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPL

Buckeye Partners

$56.33

0.64 (1.15%)

17:44
09/19/17
09/19
17:44
09/19/17
17:44
Syndicate
Buckeye Partners announces $210M in limited partnership unit sales »

Buckeye Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$91.03

0.87 (0.96%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
Ralph Lauren initiated  »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

PVH

PVH Corp.

$127.47

-0.54 (-0.42%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
PVH Corp. initiated  »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

, ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Gemphire…

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

IOVA

Iovance Biotherapeutics

$8.55

0.3 (3.64%)

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

FDX

FedEx

$216.00

0.92 (0.43%)

ADBE

Adobe

$156.60

0.83 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 22

    Oct

KORS

Michael Kors

$46.18

1.53 (3.43%)

17:42
09/19/17
09/19
17:42
09/19/17
17:42
Initiation
Michael Kors initiated  »

Michael Kors initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$39.23

-0.75 (-1.88%)

17:42
09/19/17
09/19
17:42
09/19/17
17:42
Initiation
L Brands initiated  »

L Brands initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$24.71

-0.02 (-0.08%)

17:41
09/19/17
09/19
17:41
09/19/17
17:41
Initiation
Hanesbrands initiated  »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

17:41
09/19/17
09/19
17:41
09/19/17
17:41
Recommendations
Bed Bath & Beyond analyst commentary  »

Bed Bath & Beyond Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GIII

G-III Apparel

$29.15

-0.26 (-0.88%)

17:41
09/19/17
09/19
17:41
09/19/17
17:41
Initiation
G-III Apparel initiated  »

G-III Apparel initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

-0.12 (-0.30%)

17:40
09/19/17
09/19
17:40
09/19/17
17:40
Initiation
Coach initiated  »

Coach initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.